Healthcare & Life Sciences Industry Updates

Google News – Pharmaceuticals External News

Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock By Investing.com - Investing.com Canada

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

637,500 Shares in Corvus Pharmaceuticals, Inc. $CRVS Bought by DCF Advisers LLC - MarketBeat

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Hikma Pharmaceuticals (LON:HIK) Stock Passes Above Two Hundred Day Moving Average - Should You Sell? - MarketBeat

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Great Lakes Advisors LLC Acquires Shares of 66,924 Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Phio Pharmaceuticals (PHIO) director snaps up 15,000 shares - Stock Titan

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Telix Pharmaceuticals Says FY26 Revenue And Other Income Expected To Be In Excess Of $1 Billion - TradingView

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock - TradingView

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Milestone Pharmaceuticals (MIST) Rated Overweight with $3 Price Target Amid Market Access Optimism - GuruFocus

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

The Bull Case For Lexicon Pharmaceuticals (LXRX) Could Change Following Steep Q2 Revenue Drop And Loss Shift - simplywall.st

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact SueWallSt - PR Newswire

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Crinetics Pharmaceuticals (NASDAQ:CRNX) Sees Large Volume Increase - What's Next? - MarketBeat

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 8.2% - What's Next? - MarketBeat

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Moderna (MRNA) and Merck & Company (MRK) - The Globe and Mail

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

Alnylam Pharmaceuticals (NASDAQ:ALNY): A Value Stock Worthy of Investor Attention - ChartMill

news.google.com · 21 Aug 2026

Google News – Pharmaceuticals External News

REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt - PR Newswire

news.google.com · 21 Aug 2026

News & Articles

Cancer Is Rarely Caused By One Mistake: Why Healthcare Professionals Must Improve Public Understanding

Why healthcare providers are sidelining employees amid coronavirus pandemic

Beyond AI: Why Human Empathy Will Remain Healthcare's Most Valuable Skill

UK wasted £10bn on PPE that left NHS staff poorly protected, Covid inquiry finds

Skilled labor demand is exploding. AI may be both a cause and a solution

Women are significantly underrepresented in the AI workforce

How can wearables be used in clinical trials? FDA outlines best practices

Siemens Healthineers, Philips awarded ARPA-H funds for stroke robots

Cyberattacks have plagued the medtech industry in 2026

Vapes could lead to health harms in children, doctors warn

Optimal Balance Pharmacy Issues Voluntary Nationwide Recall of Certain Lots of Compounded Glutathione 200 mg/mL Multi-Dose Vials Due to Elevated Endotoxin Levels

Gap between demand and hiring widens

Vitestro secures FDA nod for robotic blood draw device

B. Braun Medical Inc. Issues Voluntary North American Recall of Excel® Lactated Ringers Injection, 1000mL Due to the Presence of Particulate Matter

Vaccine breakthrough stops cancer returning in trial

FDA Approves First Therapy for Patients aged 8 years and older with Glycogen Storage Disease Type Ia

FDA Authorizes First-Of-Its-Kind Robotic Blood Draw Device

Trump nominates policy aide Overton to lead FDA

FDA seeks feedback on generative AI regulations

GE HealthCare names new CFO

Rocket Pharmaceuticals general counsel Martin Wilson sells $2,133 in stock By Investing.com - Investing.com Canada

637,500 Shares in Corvus Pharmaceuticals, Inc. $CRVS Bought by DCF Advisers LLC - MarketBeat

Hikma Pharmaceuticals (LON:HIK) Stock Passes Above Two Hundred Day Moving Average - Should You Sell? - MarketBeat

Great Lakes Advisors LLC Acquires Shares of 66,924 Ionis Pharmaceuticals, Inc. $IONS - MarketBeat

Phio Pharmaceuticals (PHIO) director snaps up 15,000 shares - Stock Titan

Telix Pharmaceuticals Says FY26 Revenue And Other Income Expected To Be In Excess Of $1 Billion - TradingView

Amylyx Pharmaceuticals Announces Pricing Of Upsized $500 Million Underwritten Public Offering Of Common Stock - TradingView

Milestone Pharmaceuticals (MIST) Rated Overweight with $3 Price Target Amid Market Access Optimism - GuruFocus

The Bull Case For Lexicon Pharmaceuticals (LXRX) Could Change Following Steep Q2 Revenue Drop And Loss Shift - simplywall.st

SPRY Investor Alert: ARS Pharmaceuticals Inc. Securities Class Action Notice - Contact SueWallSt - PR Newswire

Crinetics Pharmaceuticals (NASDAQ:CRNX) Sees Large Volume Increase - What's Next? - MarketBeat

Phathom Pharmaceuticals (NASDAQ:PHAT) Shares Down 8.2% - What's Next? - MarketBeat

Analysts Conflicted on These Healthcare Names: Amylyx Pharmaceuticals Inc (AMLX), Moderna (MRNA) and Merck & Company (MRK) - The Globe and Mail

Alnylam Pharmaceuticals (NASDAQ:ALNY): A Value Stock Worthy of Investor Attention - ChartMill

REGN Shareholder Alert: September 14, 2026 Lead Plaintiff Deadline in Regeneron Pharmaceuticals Securities Class Action - Contact SueWallSt - PR Newswire